Evaluate Clinical Appropriateness The most immediate strategy for cost containment is rigorous clinical oversight to limit inappropriate use
Orforglipron, for which a domestic patent has been granted, is an orally (ingestible) administered small-molecule compound currently under development by the multinational pharmaceutical company Eli Lilly and belongs to the glucagon-like peptide 1 (GLP-1) class of drugs
LY is a triple agonist that is currently being studied for its strong activity on the glucagon receptor, glucagon-like polypeptide-1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) receptors
Note: Youll need to pay the full cost for urgent prescriptions until you meet your annual deductible of $50 (or $100 maximum for your family)
As a widely used hypoglycemic drug in clinical practice, semaglutide not only regulates glucose metabolism but presents anti-inflammatory, autophagy-regulating and mitochondrial biogenesis-regulating effects, and it has also been reported to alleviate oxidative stress and improve skeletal muscle mass, all these effects independently of body weight reduction
